The Valley Desk

NCT03766685 · Interventional trial

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Overall registry status Completed

Phase 3

Conditions Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov